Back
Day Range
$19.76
$22.79
52-Week Range
$6.11
$44.60
Volume
1,792,749
50D / 200D Avg
$22.89
/
$22.80
Prev Close
$22.30
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.4 | 0.4 |
| P/B | 3.8 | 2.9 |
| ROE % | -136.2 | 3.8 |
| Net Margin % | -3777.4 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.3 | 0.2 |
Analyst Price Target
Hold
$37.00
+79.4%
Low: $19.00
High: $48.00
Forward EPS
-$4.83
Est. Revenue
9.4 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.93
-$1.31 – -$0.36
|
510 M | 1 |
| FY2029 |
-$2.68
-$3.76 – -$1.04
|
310 M | 1 |
| FY2028 |
-$3.84
-$4.93 – -$2.04
|
160 M | 5 |
Key Takeaways
Debt/Equity of 0.33 — conservative balance sheet
Negative free cash flow of -172.35M
Capital efficient — spends only 0.18% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-136.22%
ROIC-49.22%
Net Margin-3777.37%
Op. Margin-2113.85%
Safety
Debt / Equity
0.33
Current Ratio5.61
Interest Coverage0.00
Valuation
P/E Ratio
-2.44
P/B Ratio3.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 100.00% | Revenue Growth (3Y) | -55.28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10.00M | Net Income (TTM) | -377.74M |
| ROE | -136.22% | ROA | -98.46% |
| Gross Margin | 99.44% | Operating Margin | -2113.85% |
| Net Margin | -3777.37% | Free Cash Flow (TTM) | -172.35M |
| ROIC | -49.22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.33 | Current Ratio | 5.61 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -2.44 | P/B Ratio | 3.80 |
| P/S Ratio | 92.10 | PEG Ratio | -0.03 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 920.98M | Enterprise Value | 890.30M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 10.00M | 5.00M | 50.00M | 0.0 |
| Net Income | -377.74M | -156.99M | -37.12M | -119.28M |
| EPS (Diluted) | -8.44 | -3.76 | -0.97 | -3.11 |
| Gross Profit | 9.94M | -134.14M | 50.00M | -61.69M |
| Operating Income | -211.39M | -163.89M | -37.15M | -76.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 383.64M | 369.97M | 68.18M | 74.58M |
| Total Liabilities | 141.50M | 57.51M | 293.90M | 266.87M |
| Shareholders' Equity | 242.14M | 312.46M | -225.72M | -192.29M |
| Total Debt | 79.96M | 1.00M | 21.11M | 1.53M |
| Cash & Equivalents | 110.64M | 319.74M | 56.86M | 67.21M |
| Current Assets | 351.17M | 355.92M | 59.80M | 68.44M |
| Current Liabilities | 62.65M | 57.29M | 23.26M | 25.97M |